The role of interleukin 13 receptor alpha 2 in inflammatory bowel disease and colorectal cancer
Keywords:
IL-13Rα2 , Inflammatory bowel disease , Colorectal cancerAbstract
The therapeutic potential of interleukin 13 receptor alpha 2 (IL-13Rα2) has aroused considerable interest. IL-13Rα2 has long been considered to be a decoy receptor, but subsequent investigations have demonstrated that IL-13Rα2 also plays a crucial role in various inflammatory diseases and malignancies. IL-13Rα2 is capable of regulating several signaling pathways with the respective biological consequences. In this review, we summarize the role of IL-13Rα2 in inflammatory bowel disease and colorectal cancer in order to provide an updated insight into therapeutic application of IL-13Rα2.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Translational Surgical Oncology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.